TRPV1 and cancer: This innovative strategyrepresents a comprehensive approach to fine-tune the TME, significantlyamplifying the effectiveness of cancer immunotherapy by exploitingthe TRPV1 pathway and enabling in situ control ofimmunomodulation within the TME.